Safety and Efficacy of SCM-AGH in Patients With Moderate to Severe Acute Pancreatitis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
This study consists of two phases (Phase I and Phase IIa). Phase IIa will be conducted sequentially after the safety of SCM-AGH is secured in Phase I. * Phase I: Multicenter in Korea, Non-Randomized, Open-label, Single Arm, 3+3 design) for Severe Acute Pancreatitis * Phase II: Multicenter in Korea, Randomized, Double-blind, 2-arm, Placebo-controlled, Parallel arm for Moderate to Severe Acute Pancreatitis
Epistemonikos ID: 75539b551870341b7e19f693831da619b4921da9
First added on: May 06, 2024